Drugs.com - Pharma Industry News

Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score

MONDAY, April 14, 2025 -- A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disease, according to a study published in the April 10 issue of...

Apr 14, 2025 - 15:42
 0
Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score
MONDAY, April 14, 2025 -- A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disease, according to a study published in the April 10 issue of...
Read More

Tags:

Previous Article

Regulatory tracker: Europe serves up earlier lymphoma nod for Roche's Columvi as...

Next Article

Link Between Global β-Amyloid, Tau Deposition Varies by Sex

Related Posts

Immunogenic Cancer Vaccine Targets Key Mutations in Kidney Cancer

Immunogenic Cancer Vaccine Targets Key Mutations in Kid...

Feb 9, 2025  0

Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors

Depression Risk Lower With GLP-1 Receptor Agonists Vers...

Feb 25, 2025  0

Tirzepatide Dispensations Increased Rapidly After Approval

Tirzepatide Dispensations Increased Rapidly After Approval

Apr 15, 2025  0